title: Bariatric surgery: beta cells in type 2 diabetes remission.
abstract: Bariatric surgery is a new emerging treatment that demonstrates a favourable effect on type 2 diabetes, although its underlying mechanisms still remain unknown. After receiving bariatric surgery, beta cells undergo the process of rebirth, which involves apoptosis evasion, regeneration and improved beta-cell function. Therefore, further studies are necessary to elucidate how bariatric surgery can resolve type 2 diabetes. Here, our review focuses mainly on beta cells, the insulin-generating cells, whose biological features change dramatically after bariatric surgery. Copyright © 2015 John Wiley & Sons, Ltd.
authors.affiliation: Battalion 8th, Trainee Brigade, Third Military Medical University, Chongqing, China.
authors.forename: Yinjie
authors.initials: Y
authors.lastname: Su
authors.affiliation: Department of Gynaecology and Obstetrics, The Health Center of Kumutamu, Aksu City, Xinjiang Province, China.
authors.forename: Yanling
authors.initials: Y
authors.lastname: Zhao
authors.affiliation: Department of General Surgery, Xinqiao Hospital, Third Military Medical University, Chongqing, China.
authors.forename: Chaojun
authors.initials: C
authors.lastname: Zhang
mesh_terms: D050110:Bariatric Surgery; D003924:Diabetes Mellitus, Type 2 / Q000517:prevention & control*; D006801:Humans; D050417:Insulin-Secreting Cells; D016896:Treatment Outcome
keywords: bariatric surgery; beta cells; type 2 diabetes